STOCK TITAN

Clene Inc. Rob Etherington, CEO, and Morgan Brown, CFO, to Present at the Investor Summit Virtual on March 11

Clene (CLNN) has announced its participation in the upcoming Investor Summit Virtual event scheduled for March 11, 2025.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Clene (CLNN) has announced its participation in the upcoming Investor Summit Virtual event scheduled for March 11, 2025. The company will be represented by two key executives: Rob Etherington, Chief Executive Officer, and Morgan Brown, Chief Financial Officer, who will be presenting at the virtual conference.

Loading...
Loading translation...
Argus Session date unavailable
+3.51% session move Open Argus
Details

News Market Reaction – CLNN

The recorded move for CLNN in the trading session of this news was +3.51%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

NEW YORK, NY / ACCESS Newswire / February 27, 2025 / Rob Etherington, CEO, and Morgan Brown, CFO, of Clene Inc., will be presenting at this year's Investor Summit Virtual on March 11th.

About Clene Inc.
Clene Inc. is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson's disease, and multiple sclerosis. CNM-Au8® is an investigational first-in-class therapy that improves central nervous system cells' survival and function via a mechanism that targets mitochondrial function and the NAD pathway while reducing oxidative stress. CNM-Au8® is a federally registered trademark of Clene Nanomedicine, Inc. The company is based in Salt Lake City, Utah, with R&D and manufacturing operations in Maryland.

Event: Q1 Investor Summit
Presentation Time:1:00 PM ET
Location: https://www.webcaster4.com/Webcast/Page/3082/52092

Conference Overview and Structure
The Investor Summit is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the most attractive small companies, learn from various subject matter experts, and see what your peers are doing in this market.

This quarter's event is focused on MicroCap companies who are undervalued, have a catalyst, and are undervalued.

Registration for Investors
To request free registration, please go to our website (https://investorsummitgroup.com/), and click the "Registration" button.

Sponsors:

  • AccessNewswire

  • PCG Advisory

  • QuoteMedia

  • AGP

  • MZ Group

News Compliments of ACCESSWIRE NEWSWIRE

For More Information
Please visit: https://investorsummitgroup.com/
Or, contact johnna-mae@investorsummitgroup.com

SOURCE: Clene Inc.



View the original press release on ACCESS Newswire

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Clene (CLNN) presenting at the Investor Summit Virtual 2025?

Clene (CLNN) will present at the Investor Summit Virtual on March 11, 2025.

Who will represent CLNN at the March 2025 Investor Summit Virtual?

CEO Rob Etherington and CFO Morgan Brown will represent Clene at the event.

What type of event is the Investor Summit where CLNN is presenting?

The Investor Summit is a virtual conference where companies present to investors.

Where will the CLNN Investor Summit presentation take place?

The presentation will take place virtually as part of the Investor Summit Virtual event.

Keep reading